BIOMAT Database Logo BIOMAT Database Logo

Human erythrocytes bearing electroinserted CD4 neutralize infection in vitro by primary isolates of human immunodeficiency virus type 1. 1996

P F Tosi, and D Schwartz, and U Sharma, and Y Mouneimne, and J Hannig, and G Li, and G McKinley, and M Grieco, and C W Flexner, and J Lazarte, and D Norse, and C Nicolau, and D J Volsky
Center for Blood Research Laboratory and Harvard Medical School, Boston, MA, USA.

Human erythrocytes bearing electroinserted full-length CD4 (RBC-CD4) can bind and fuse with a laboratory strain of human immunodeficiency virus type 1 (HIV-1) or with T cells infected by HIV-1. Here we show that RBC-CD4 neutralize primary HIV-1 strains in an assay of cocultivation of peripheral blood mononuclear cells (PBMC) from HIV-1-infected persons with uninfected PBMC. RBC-CD4 inhibited viral p24 core antigen accumulation in these cocultures up to 10,000-fold compared with RBC alone. Viral p24 accumulation was inhibited equally well when measured in culture supernatants or in call extracts. The inhibition was dose-dependent and long-lived. Two types of recombinant CD4 tested in parallel were largely ineffective. The neutralization of primary HIV-1 by RBC-CD4 in vitro was demonstrated in PBMC cultures from 21 of a total of 23 patients tested at two independent sites. RBC-CD4 may offer a route to blocking HIV-1 infection in vivo.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D004910 Erythrocyte Membrane The semi-permeable outer structure of a red blood cell. It is known as a red cell 'ghost' after HEMOLYSIS. Erythrocyte Ghost,Red Cell Cytoskeleton,Red Cell Ghost,Erythrocyte Cytoskeleton,Cytoskeleton, Erythrocyte,Cytoskeleton, Red Cell,Erythrocyte Cytoskeletons,Erythrocyte Ghosts,Erythrocyte Membranes,Ghost, Erythrocyte,Ghost, Red Cell,Membrane, Erythrocyte,Red Cell Cytoskeletons,Red Cell Ghosts
D004912 Erythrocytes Red blood cells. Mature erythrocytes are non-nucleated, biconcave disks containing HEMOGLOBIN whose function is to transport OXYGEN. Blood Cells, Red,Blood Corpuscles, Red,Red Blood Cells,Red Blood Corpuscles,Blood Cell, Red,Blood Corpuscle, Red,Erythrocyte,Red Blood Cell,Red Blood Corpuscle
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000163 Acquired Immunodeficiency Syndrome An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993. AIDS,Immunodeficiency Syndrome, Acquired,Immunologic Deficiency Syndrome, Acquired,Acquired Immune Deficiency Syndrome,Acquired Immuno-Deficiency Syndrome,Acquired Immuno Deficiency Syndrome,Acquired Immuno-Deficiency Syndromes,Acquired Immunodeficiency Syndromes,Immuno-Deficiency Syndrome, Acquired,Immuno-Deficiency Syndromes, Acquired,Immunodeficiency Syndromes, Acquired,Syndrome, Acquired Immuno-Deficiency,Syndrome, Acquired Immunodeficiency,Syndromes, Acquired Immuno-Deficiency,Syndromes, Acquired Immunodeficiency
D001667 Binding, Competitive The interaction of two or more substrates or ligands with the same binding site. The displacement of one by the other is used in quantitative and selective affinity measurements. Competitive Binding
D014779 Virus Replication The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle. Viral Replication,Replication, Viral,Replication, Virus,Replications, Viral,Replications, Virus,Viral Replications,Virus Replications
D015496 CD4-Positive T-Lymphocytes A critical subpopulation of T-lymphocytes involved in the induction of most immunological functions. The HIV virus has selective tropism for the T4 cell which expresses the CD4 phenotypic marker, a receptor for HIV. In fact, the key element in the profound immunosuppression seen in HIV infection is the depletion of this subset of T-lymphocytes. T4 Cells,T4 Lymphocytes,CD4-Positive Lymphocytes,CD4 Positive T Lymphocytes,CD4-Positive Lymphocyte,CD4-Positive T-Lymphocyte,Lymphocyte, CD4-Positive,Lymphocytes, CD4-Positive,T-Lymphocyte, CD4-Positive,T-Lymphocytes, CD4-Positive,T4 Cell,T4 Lymphocyte

Related Publications

P F Tosi, and D Schwartz, and U Sharma, and Y Mouneimne, and J Hannig, and G Li, and G McKinley, and M Grieco, and C W Flexner, and J Lazarte, and D Norse, and C Nicolau, and D J Volsky
Soluble CD4 molecules neutralize human immunodeficiency virus type 1.
January 1988, Nature,
P F Tosi, and D Schwartz, and U Sharma, and Y Mouneimne, and J Hannig, and G Li, and G McKinley, and M Grieco, and C W Flexner, and J Lazarte, and D Norse, and C Nicolau, and D J Volsky
High concentrations of recombinant soluble CD4 are required to neutralize primary human immunodeficiency virus type 1 isolates.
September 1990, Proceedings of the National Academy of Sciences of the United States of America,
P F Tosi, and D Schwartz, and U Sharma, and Y Mouneimne, and J Hannig, and G Li, and G McKinley, and M Grieco, and C W Flexner, and J Lazarte, and D Norse, and C Nicolau, and D J Volsky
High concentrations of recombinant soluble CD4 are required to neutralize primary human immunodeficiency virus type-I isolates.
January 1991, Disease markers,
P F Tosi, and D Schwartz, and U Sharma, and Y Mouneimne, and J Hannig, and G Li, and G McKinley, and M Grieco, and C W Flexner, and J Lazarte, and D Norse, and C Nicolau, and D J Volsky
Recombinant human Fab fragments neutralize human type 1 immunodeficiency virus in vitro.
October 1992, Proceedings of the National Academy of Sciences of the United States of America,
P F Tosi, and D Schwartz, and U Sharma, and Y Mouneimne, and J Hannig, and G Li, and G McKinley, and M Grieco, and C W Flexner, and J Lazarte, and D Norse, and C Nicolau, and D J Volsky
Cross-clade inhibition of human immunodeficiency virus type 1 primary isolates by monoclonal anti-CD4.
June 1998, The Journal of infectious diseases,
P F Tosi, and D Schwartz, and U Sharma, and Y Mouneimne, and J Hannig, and G Li, and G McKinley, and M Grieco, and C W Flexner, and J Lazarte, and D Norse, and C Nicolau, and D J Volsky
Destruction of primary CD4(+) T cells by cell-cell interaction in human immunodeficiency virus type 1 infection in vitro.
August 2000, The Journal of general virology,
P F Tosi, and D Schwartz, and U Sharma, and Y Mouneimne, and J Hannig, and G Li, and G McKinley, and M Grieco, and C W Flexner, and J Lazarte, and D Norse, and C Nicolau, and D J Volsky
Primary human immunodeficiency virus type 1 infection.
June 2005, Current HIV/AIDS reports,
P F Tosi, and D Schwartz, and U Sharma, and Y Mouneimne, and J Hannig, and G Li, and G McKinley, and M Grieco, and C W Flexner, and J Lazarte, and D Norse, and C Nicolau, and D J Volsky
CD4-independent infection of human neural cells by human immunodeficiency virus type 1.
June 1989, Journal of virology,
P F Tosi, and D Schwartz, and U Sharma, and Y Mouneimne, and J Hannig, and G Li, and G McKinley, and M Grieco, and C W Flexner, and J Lazarte, and D Norse, and C Nicolau, and D J Volsky
Human immunodeficiency virus type 1 infection of human CD4-transgenic rabbits.
June 1995, The Journal of general virology,
P F Tosi, and D Schwartz, and U Sharma, and Y Mouneimne, and J Hannig, and G Li, and G McKinley, and M Grieco, and C W Flexner, and J Lazarte, and D Norse, and C Nicolau, and D J Volsky
CD4-independent infection of human peripheral blood dendritic cells with isolates of human immunodeficiency virus type 1.
July 1993, The Journal of general virology,
Copied contents to your clipboard!